Project factsheets

Learn more about the projects supported by IHI as well as the Innovative Medicines Initiative (IMI).

IHI/IMI2/IMI1

Status

Call

Programmes

Disease areas

Products

Tools and resources to improve drug development

Clear all filters

Displaying 13 projects/programmes

3TR

Identification of the molecular mechanisms of non-response to treatments, relapses and remission in autoimmune, inflammatory, and allergic conditions

BIOMAP

Biomarkers in atopic dermatitis and psoriasis

Ongoing IMI2 Autoimmune diseases Skin diseases Biobanks Disease taxonomy

BTCure

Be The Cure

Closed IMI1 Autoimmune diseases Tools for predicting/monitoring safety Disease taxonomy

CLAIMS

Clinical impact through AI-assisted MS care

Ongoing IHI Autoimmune diseases Big data and knowledge management Artificial intelligence

H2O

H2O Health outcomes observatory

Ongoing IMI2 Diabetes & metabolic disorders Autoimmune diseases Cancer Patient involvement in R&D Real-world data, evidence

HIPPOCRATES

Health initiatives in psoriasis and psoriatic arthritis consortium European states

Ongoing IMI2 Autoimmune diseases Skin diseases Biobanks Clinical networks Disease taxonomy Artificial intelligence

IDEA-FAST

Identifying digital endpoints to assess fatigue, sleep and activities in daily living in neurodegenerative disorders and immune-mediated inflammatory diseases

Ongoing IMI2 Neurodegenerative diseases Autoimmune diseases Clinical trial design Digital health Real-world data, evidence

ImmUniverse

Better control and treatment of immune-mediated diseases by exploring the universe of microenvironment imposed tissue signatures and their correlates in liquid biopsies

Ongoing IMI2 Autoimmune diseases Skin diseases Tools for predicting/monitoring efficacy Disease taxonomy

imSAVAR

Immune safety avatar: nonclinical mimicking of the immune system effects of immunomodulatory therapies

Ongoing IMI2 Autoimmune diseases Cancer 3Rs - animal use in research

NECESSITY

New clinical endpoints in primary Sjögren’s syndrome: an interventional trial based on stratifying patients

Ongoing IMI2 Autoimmune diseases Tools for predicting/monitoring efficacy Clinical trial design Disease taxonomy

PRECISESADS

Molecular reclassification to find clinically useful biomarkers for systemic autoimmune diseases

Closed IMI1 Autoimmune diseases Diagnostics Conducting clinical trials

RTCure

Rheuma Tolerance for Cure

Ongoing IMI2 Autoimmune diseases Biologicals Tools for predicting/monitoring efficacy Tools for predicting/monitoring safety Disease taxonomy

ULTRA-DD

Unrestricted leveraging of targets for research advancement and drug discovery

Closed IMI1 Autoimmune diseases Drug discovery